NDC包装代码 | 产品NDC | 产品类型 | 商品名 | 通用名 | 剂型 | 给药途径 | 上市日期 | 结束日期 | 市场类别 | 申请号 | 标签持有者 | 活性成分 | 规格 | 包装描述 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
71090-001-01 | 71090-001 | HUMAN PRESCRIPTION DRUG | Keveyis | Dichlorphenamide | TABLET | ORAL | 20170221 | 20251023 | NDA | NDA011366 | Strongbridge US Inc. | DICHLORPHENAMIDE | 50 mg/1 | 100 TABLET in 1 BOTTLE (71090-001-01) |
72065-002-01 | 72065-002 | HUMAN PRESCRIPTION DRUG | Dichlorphenamide | Dichlorphenamide | TABLET | ORAL | 20230310 | N/A | NDA AUTHORIZED GENERIC | NDA011366 | Xeris Pharmaceuticals, Inc. | DICHLORPHENAMIDE | 50 mg/1 | 100 TABLET in 1 BOTTLE (72065-002-01) |
72065-001-01 | 72065-001 | HUMAN PRESCRIPTION DRUG | Keveyis | Dichlorphenamide | TABLET | ORAL | 20211213 | N/A | NDA | NDA011366 | Xeris Pharmaceuticals, Inc. | DICHLORPHENAMIDE | 50 mg/1 | 100 TABLET in 1 BOTTLE (72065-001-01) |